Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.8K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.4K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Peptide-Based Delivery Systems: Selected Insights into Cell-Penetrating Peptides.

ACS chemical neuroscience·2026
Same author

Racemisation of Amino Acids: From Synthetic Challenge to Biological Significance.

Chembiochem : a European journal of chemical biology·2026
Same author

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Gynecologic oncology·2026
Same author

Self-Assembly of Peptides and Biomolecular Systems Into Functional Nanomaterials.

Journal of peptide science : an official publication of the European Peptide Society·2026
Same author

Strength in Recovery: A Practice-Informed Commentary on Peer Recovery Specialists Facilitating Gambling Recovery Groups.

Journal of gambling studies·2026
Same author

Application of the OBIMAP (One-Bead Interchain Multipeptide Assembly Platform) to Long Peptide Synthesis: Liraglutide as a Case Study.

ACS omega·2026

相关实验视频

Updated: Sep 15, 2025

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.6K

抑制剂:打破癌症的代码

Fleur Coburn1, Yanyamba Nsereko1, Amy Armstrong1

  • 1School of Pharmacy, Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK.

European journal of medicinal chemistry
|July 17, 2025
PubMed
概括
此摘要是机器生成的。

抑制剂提供了一种选择性的方法来向瘤信号通路,克服传统化疗的局限性. 的设计和交付方面的创新正在提高它们对抗癌症的疗效,临床试验中有几种候选药物.

关键词:
癌症 癌症 癌症 癌症抑制剂 抑制剂 抑制剂酸是一种酸.拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉斯信号通道是指信号通道.在mTOROR中使用mTOR.

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

相关实验视频

Last Updated: Sep 15, 2025

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 瘤信号通路对于癌症的发展和进展至关重要.
  • 传统化疗面临诸多挑战,包括毒性和耐药性.
  • 类抑制剂通过破坏致癌途径来呈现有针对性的治疗策略.

研究的目的:

  • 审查提高基于的癌症药物的疗效的策略.
  • 探索针对关键癌症途径的抑制剂的机制.
  • 突出目前的研究和干预的临床潜力.

主要方法:

  • 对癌症治疗中的抑制剂现有文献的综述.
  • 对酸设计创新的分析 (例如,循环,纳米粒子输送).
  • 对大鼠肉瘤蛋白 (RAS) 和哺乳动物目标拉巴胺素 (mTOR) 途径的特定向机制的检查.

主要成果:

  • 已经确定了几种针对RAS和mTOR途径的类抑制剂.
  • 例如包括KRpep-2D,LUNA18和一个突变的KRAS疫苗.
  • 突变KRAS疫苗和LUNA18显示出有前途的临床潜力,目前正在试验中.

结论:

  • 抑制剂是传统癌症治疗的有希望的替代品.
  • 目前正在进行的研究重点是克服稳定性,交付和阻力挑战.
  • 先进的疗法正在向临床应用迈进.